A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care
- 16 April 2012
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 29 (8) , e191-e198
Abstract
Diabet. Med. 29, e191–e198 (2012) Aims This study characterized UK primary care patients with Type 2 diabetes who initiated insulin treatment, and described the initial insulin regimens used, overall metabolic changes and health‐care resource usage.Methods A retrospective cohort study was performed using quality‐checked patient data from The Health Improvement Network database. Eligible patients who initiated insulin for the first time between 2004 and 2006 were grouped into four cohorts according to the type of insulin regimen initiated. Data on patient characteristics, metabolic and clinical outcomes and health‐care resource use were collected at baseline and during 6 months of follow‐up.Results In total, 4045 eligible adults [2269 male, 1776 female; mean age 62.6 ± 13.3 years; mean baseline HbA1c 82 ± 22 mmol/mol (9.6% ± 2.0%)] initiated insulin. Approximately half (52.4%) initiated insulin as basal insulin only, 41.6% as premixed only, 4.0% as basal‐bolus and 2.1% as prandial insulin only. Among patients with ≥ 180 days follow‐up (n = 3815), the initial insulin regimen was not changed during follow‐up in 75.1% of patients, while 13.7% discontinued, 7.0% switched and 4.7% intensified insulin therapy. The mean change in HbA1c was −14 mmol/mol (−1.3%, n = 2881), with 17.3% of patients achieving an HbA1c of < 53 mmol/mol (7%, n = 3024). The mean weight change was +0.9 kg (n = 2345).Conclusions Basal and premixed insulin were the most common types of insulin initiated and in most patients no changes were made to the initial regimen over 6 months. However, few patients achieved glycemic control targets.Keywords
This publication has 23 references indexed in Scilit:
- A comparison of intermediate and long‐acting insulins in people with type 2 diabetes starting insulin: an observational database studyInternational Journal Of Clinical Practice, 2010
- Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*Current Medical Research and Opinion, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysisCurrent Medical Research and Opinion, 2008
- Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic ControlJournal of General Internal Medicine, 2007
- Validation studies of the health improvement network (THIN) database for pharmacoepidemiology researchPharmacoepidemiology and Drug Safety, 2006
- A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 DiabetesDiabetes Care, 2006
- Mortality in people with Type 2 diabetes in the UKDiabetic Medicine, 2006
- The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitusDiabetes, 1985
- Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawalDiabetes, 1984